Canada Opens Access for Psilocybin and MDMA Therapy
Cannabis Law Report
FEBRUARY 24, 2022
Each request is decided on a patient-by-patient basis and approval is usually only given to drugs with successful phase II or phase II clinical trials. In 2013, section C and J of Canada’s FDR statute were amended so that “restricted drugs” were inaccessible through SAP. Subsection 56(1) Exemption.
Let's personalize your content